PRTK - Paratek Pharmaceuticals, Inc.

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-88,662
-63,566
-59,084
-96,541
-128,790
Depreciation & amortisation
483
490
391
578
-1,292
Stock-based compensation
15,189
12,319
14,336
10,248
14,295
Change in working capital
-179
-20,791
-8,189
-20,286
-21,499
Accounts receivable
-10,394
-40,424
-21,785
-7,459
-11,228
Inventory
-21,149
-9,092
-15,504
-11,760
-10,856
Other working capital
-65,872
-66,177
-48,646
-103,800
-134,284
Other non-cash items
7,333
5,407
4,273
1,518
3,241
Net cash provided by operating activities
-65,836
-66,141
-48,273
-103,424
-134,045
Cash flows from investing activities
Investments in property, plant and equipment
-36
-36
-373
-376
-239
Purchases of investments
-30,277
-15,160
-15,117
-29,625
-102,207
Sales/maturities of investments
0
30,000
20,000
122,500
237,000
Net cash used for investing activities
-30,313
14,804
4,510
92,499
134,554
Cash flows from financing activities
Debt repayment
-2,888
-2,888
-319
-70,000
-
Common stock issued
11,644
7,329
18,392
21,891
26,559
Other financing activities
-
-
-397
-
-
Net cash used provided by (used for) financing activities
12,112
5,093
18,332
11,340
57,622
Net change in cash
-84,037
-46,244
-25,431
415
58,131
Cash at beginning of period
111,249
80,617
106,048
105,633
47,502
Cash at end of period
27,212
34,373
80,617
106,048
105,633
Free cash flow
Operating cash flow
-65,836
-66,141
-48,273
-103,424
-134,045
Capital expenditure
-36
-36
-373
-376
-239
Free cash flow
-65,872
-66,177
-48,646
-103,800
-134,284